Analysis of COVID-19 clinical course among vaccinated against SARS-CoV-2 people in the Khabarovsk krai

Author:

Bazykina E. A.1ORCID,Trotsenko O. E.1,Zaitseva T. A.2,Karavyanskaya T. N.2

Affiliation:

1. Khabarovsk Research Institute of Epidemiology and Microbiology of Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)

2. Khabarovsk Krai Regional Office of Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Abstract

Aim. To analyze clinical manifestations of novel coronavirus infection among vaccinated population of the Khabarovsk krai with breakthrough infection.Materials and methods. Analysis was based on official data including information on COVID-19 breakthrough infections provided by Khabarovsk krai Rospotrebnadzor regional office. Statistical analysis included calculation of Spearman's rank correlation, odds ratio.Results. A relatively small proportion (0.7%) of breakthrough COVID-cases that occurred among Khabarovsk residents vaccinated against SARS-CoV-2 was shown during analyzed period of time. The highest risk of contracting COVID-19 was revealed among people aged over 50 years. Course of breakthrough COVID-19 infection was mostly mild ‒ 61.0% (95% CI: 54.2‒67.6%). In most cases COVID-19 manifested itself as acute respiratory viral infection ‒ 66.7% (95% CI: 60.0‒73.0%). A significant negative correlation was noted between levels of blood saturation and duration of the disease (ρ=-0.82; p<0.05). Duration of COVID- 19 among vaccinated people was 16 days in for patients treated in an outpatient facility and 17 days for hospitalized patients in average. Most common clinical manifestations of COVID-19, noted by more than half of the respondents, were hyperthermia ‒ 55.7% (95% CI: 48.8–62.5%), weakness and cough ‒ 65.7% each (95% CI: 59.1–72,2%).Conclusion. Obtained data testify in favor of significant protective potential of vaccines against COVID-19.

Publisher

Far Eastern Scientific Center Of Physiology and Pathology of Respiration

Subject

General Medicine

Reference10 articles.

1. Logunov D.Y., Dolzhikova I.V., Shcheblyakov D.V., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S., Kovyrshina A.V., Lubenets N.L., Grousova D.M., Erokhova A.S., Botikov A.G., Izhaeva F.M., Popova O., Ozharovskaya T.A., Esmagambetov I.B., Favorskaya I.A., Zrelkin D.I., Voronina D.V., Shcherbinin D.N., Semikhin A.S., Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 2021; 397(10275):671–681. https://doi.org/10.1016/S0140-6736(21)00234-8

2. Eskendirova Z.M., Mutusheva A.T., Dukaeva Zh.K., Solopenko M.Zh., Kalibaeva N.K. [Coronavirus infection in people vaccinated against COVID-19]. Valeology: Health – Illness – Recovery (Kazakhstan) 2021; (3):76‒77 (in Russian).

3. Linets Yu.P., Artyukhov S.V., Kazantsev A.N., Zaitseva T.Y., Roshkovskaya L.V., Sokolova S.V., Chikin A.Y., Yenova G.K., Kondakov S.B. COVID-19 Course in Vaccinated Patients. Russian Sklifosovsky Journal "Emergency Medical Care". 2021; 10(4):636‒641. https://doi.org/10.23934/2223-9022-2021-10-4-636-641

4. Borisova A.A., Popova N.D., Kychkina A.I., Rozhina A.A., Fedulova A.G. [Epidemiological characteristics of the dynamics of a new coronavirus infection (COVID-19) in the Republic of Sakha (Yakutia)]. International Research Journal 2022; 1-2 (115):84‒87 (in Russian). https://doi.org/10.23670/IRJ.2022.115.1.057

5. Kolobukhina L.V., Burgasova O.A., Kruzhkova I.S., Bakalin V.V., Generalova L.V., Shagaev A.V., Ogarkova D.A., Nikiforova M.A., Vasina D.V., Gushchin V.A., Smetanina S.V. Assessment of COVID-19 clinical course in patients vaccinated with Sputnik V, SARS-CoV-2 S protein RBD domain variation and serum virus neutralizing activity. Bulletin of Russian State Medical University 2021; (5):62‒70. https://doi.org/10.24075/brsmu.2021.046

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3